Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at ...
A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...
Researchers from The Institute of Cancer Research, London, and Barts Cancer Institute have discovered how the extracellular matrix (ECM) surround ...
Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...
Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update ...
EXCLUSIVE: Retired David Mather was dealt a shocking blow when told his tiredness was stage-IV lung cancer - now a new UK ...
Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination.
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.
GlobalData on MSN4d
Radiopharm’s imaging molecule hits mark in observational trialThe company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback